RÉDOVÁ, Martina, Petr CHLAPEK, Tomáš LOJA, Karel ZITTERBART, Markéta HERMANOVÁ, Jaroslav ŠTĚRBA and Renata VESELSKÁ. Influence of LOX/COX inhibitors on cell differentiation induced by all-trans retinoic acid in neuroblastoma cell lines. International Journal of Molecular Medicine. Athens: Spandidos Ltd., 2010, vol. 25, No 2, p. 271-280. ISSN 1107-3756.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Influence of LOX/COX inhibitors on cell differentiation induced by all-trans retinoic acid in neuroblastoma cell lines.
Name in Czech Vliv LOX/COX inhibitorů na buněčnou diferenciaci indukovanou aplikací kyseliny all-trans retinové u neuroblastomových buněčných linií.
Authors RÉDOVÁ, Martina (203 Czech Republic, belonging to the institution), Petr CHLAPEK (203 Czech Republic, belonging to the institution), Tomáš LOJA (703 Slovakia, belonging to the institution), Karel ZITTERBART (203 Czech Republic, belonging to the institution), Markéta HERMANOVÁ (203 Czech Republic, belonging to the institution), Jaroslav ŠTĚRBA (203 Czech Republic, belonging to the institution) and Renata VESELSKÁ (203 Czech Republic, guarantor, belonging to the institution).
Edition International Journal of Molecular Medicine, Athens, Spandidos Ltd. 2010, 1107-3756.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30200 3.2 Clinical medicine
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 1.814
RIV identification code RIV/00216224:14310/10:00040728
Organization unit Faculty of Science
UT WoS 000273862300013
Keywords in English neuroblastoma; caffeic acid; celecoxibe; all-trans retinoic acid; cell differentiation
Tags International impact, Reviewed
Changed by Changed by: prof. RNDr. Renata Veselská, Ph.D., M.Sc., učo 1260. Changed: 24/1/2011 10:03.
Abstract
We investigated the possible modulation by LOX/ COX inhibitors of all-trans retinoic acid (ATRA)-induced cell differentiation in two established neuroblastoma cell lines, SH-SY5Y and SK-N-BE(2). Caffeic acid, as an inhibitor of 5-lipoxygenase, and celecoxib, as an inhibitor of cyclooxygenase-2, were chosen for this study. The effects of the combined treatment with ATRA and LOX/COX inhibitors on neuroblastoma cells were studied using cell morphology assessment, detection of differentiation markers by immunoblotting, measurement of proliferation activity, and cell cycle analysis and apoptosis detection by flow cytometry. The results clearly demonstrated the potential of caffeic acid to enhance ATRA-induced cell differentiation, especially in the SK-N-BE(2) cell line, whereas application of celecoxib alone or with ATRA led predominantly to cytotoxic effects in both cell lines.
Abstract (in Czech)
V rámci studie byly na dvou stabilizovaných buněčných liniích, SH-SY5Y a SK-N-BE(2), zkoumány možnosti modulace ATRA-indukované buněčné diferenciace kombinovanou aplikací s LOX/COX inhibitory. V experimentech byla použita kyselina kávová jako inhibitor 5-lipoxygenázy a celecoxib jako inhibitor cyklooxygenázy-2; účinky jejich kombinovaného působení s ATRA byly sledovány na úrovni hodnocení změn buněčné morfologie, detekce diferenciačních markerů pomocí imunoblottingu, měření proliferační aktivity, analýzou buněčného cyklu a detekcí apoptózy pomocí flow cytometrie. Výsledky experimentů jasně prokázaly schopnost kyseliny kávové zesilovat ATRA-indukovanou buněčnou diferenciaci, zejména u linie SK-N-BE(2), zatímco aplikace celecoxibu - ať už samostatně nebo v kombinaci s ATRA - vykazovala u obou linií zejména cytotoxický efekt.
Links
GD204/08/H054, research and development projectName: Molekulární mechanismy proliferace a diferenciace buněk
Investor: Czech Science Foundation, Molecular mechanisms of the cell proliferation and differentiation
MSM0021622415, plan (intention)Name: Molekulární podstata buněčných a tkáňových regulací
Investor: Ministry of Education, Youth and Sports of the CR, Molecular basis of cell and tissue regulations
NR9341, research and development projectName: Modulace antineoplastického efektu retinoidů LOX/COX inhibitory na modelu dětských solidních nádorů: in vitro studie
Investor: Ministry of Health of the CR
PrintDisplayed: 26/4/2024 09:27